Two Sigma Investments’s Kiora Pharmaceuticals KPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$102K Sell
39,944
-48,848
-55% -$126K ﹤0.01% 4690
2026
Q2
$234K Buy
+88,792
New +$223K ﹤0.01% 4683
2025
Q4
– Sell
-11,984
Closed -$33.3K – 4255
2025
Q3
$33.3K Buy
+11,984
New +$32.9K ﹤0.01% 3564
2024
Q2
– Sell
-1,150
Closed -$7.31K – 3189
2024
Q1
$7.31K Buy
+1,150
New +$6.43K ﹤0.01% 2965
2021
Q3
– Sell
-75
Closed -$99K – 4488
2021
Q2
$99K Sell
75
-72
-49% -$112K ﹤0.01% 3899
2021
Q1
$263K Buy
+147
New +$320K ﹤0.01% 3433

Other funds holding KPRX

Two Sigma Investments's KPRX Position: Q3 2026 in Review

Two Sigma Investments reduced its Kiora Pharmaceuticals (KPRX) stake by 55% in Q3 2026, selling an estimated $126K and leaving 39,944 shares worth $102K. The position accounts for ﹤0.01% of the portfolio, ranked #4690.

Two Sigma Investments first reported a position in KPRX in Q1 2021 and has held it in 6 quarters since. The position peaked at $263K in Q1 2021. 21 funds tracked by Wall St. Rank hold KPRX as of Q3 2026.

  • Two Sigma Investments held 39,944 shares of Kiora Pharmaceuticals worth $102K as of Q3 2026.
  • Two Sigma Investments sold 48,848 Kiora Pharmaceuticals shares in Q3 2026, an estimated $126K.
  • Kiora Pharmaceuticals made up ﹤0.01% of Two Sigma Investments's portfolio in Q3 2026, its #4690 holding.
  • Two Sigma Investments first reported a position in Kiora Pharmaceuticals in Q1 2021 and has held it in 6 quarters since.
  • Two Sigma Investments's Kiora Pharmaceuticals position peaked at $263K in Q1 2021.
  • 21 funds tracked by Wall St. Rank held Kiora Pharmaceuticals as of Q3 2026.

Based on Two Sigma Investments's 13F filing for Q3 2026, filed 16 Nov 2026.